Sponsor-Investigators

Mylin A. Torres

HCRN-BRE19-433

A Multi-institutional Phase II Study to Evaluate Efficacy and Safety of TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 negative Patients with PD-L1+ Metastatic Triple Negative Breast Cancer (TARA)

Status

Closed

Cancer Types

Breast

Locations